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Aromatase Knockout Mice Show Normal Steroid-Induced Activation of
Gonadotrophin-Releasing Hormone Neurones and Luteinising Hormone
Surges With a Reduced Population of Kisspeptin Neurones in the Rostral
Hypothalamus
L. Szymanski and J. Bakker
GIGA Neurosciences, University of Lie`ge, Lie`ge, Belgium.
The capacity to generate a preovulatory surge of gonadotrophin-
releasing hormone (GnRH) ⁄ luteinising hormone (LH) in response to
gonadal steroids is perhaps the most robust sexually differentiated
endocrine response in rodents, with only females being capable of
generating regular LH surges. The release of LH from the pituitary is
stimulated by the secretion of GnRH from a diffuse population of
neurones in the hypothalamus, which is in turn modulated by the
actions of circulating oestradiol and progesterone. During most of
the oestrous cycle, oestrogens exert a negative-feedback on the
hypothalamic-pituitary axis. By contrast, on the afternoon of pro-oe-
strous, oestrogens and ⁄ or progesterone exert a positive-feedback on
the hypothalamic-pituitary axis, leading to a massive release of GnRH
and, subsequently, LH, and in turn to ovulation, at the same time as
facilitating sexual behaviour (1–3). Thus, ovarian oestradiol secreted
from metoestrous through early pro-oestrous by the developing folli-
cle stimulates the release of GnRH and sensitises the pituitary gland
to become more responsive to hypothalamic GnRH (4). The hypotha-
lamic-pituitary axis in males, on the other hand, does not show posi-
tive-feedback in response to oestradiol and males are not able to
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We recently reported that female aromatase knockout (ArKO) mice show deficits in sexual
behaviour and a decreased population of kisspeptin-immunoreactive neurones in the rostral
periventricular area of the third ventricle (RP3V), resurrecting the question of whether oestradiol
actively contributes to female-typical sexual differentiation. To further address this question, we
assessed the capacity of ArKO mice to generate a steroid-induced luteinising hormone (LH)
surge. Adult, gonadectomised wild-type (WT) and ArKO mice were given silastic oestradiol
implants s.c. and, 1 week later, received s.c. injections of either oestradiol benzoate (EB) followed
by progesterone, EB alone, or no additional steroids to activate gonadotrophin-releasing hor-
mone (GnRH) neurones and generate an LH surge. Treatment with EB and progesterone induced
significant Fos ⁄GnRH double-labelling and, consequently, an LH surge in female WT and in ArKO
mice of both sexes but not in male WT mice. ArKO mice of both sexes had fewer cells express-
ing Kiss-1 mRNA in the RP3V compared to female WT mice but had more Kiss-1 mRNA-express-
ing cells compared to WT males, reflecting an incomplete sexual differentiation of this system.
To determine the number of cells expressing kisspeptin, the same experimental design was
repeated in Experiment 2 with the addition of groups of WT and ArKO mice that were given
EB + progesterone and sacrificed 2 h before the expected LH surge. No differences were
observed in the number of kisspeptin-immunoreactive cells 2 h before and at the time of the
LH surge. The finding that ArKO mice of both sexes have a competent LH surge system suggests
that oestradiol has predominantly defeminising actions on the GnRH ⁄ LH surge system in males
and that the steroid-induced LH surge can occur in females even with a greatly reduced popula-
tion of kisspeptin neurones in the RP3V.
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This sex difference in the GnRH ⁄ LH surge system appears to be
organised by the perinatal actions of testosterone and ⁄ or oestradiol
on the hypothalamus (6, 7). In rodents, neonatal castration feminis-
es the ability of males to show the capacity to generate an LH
surge, and treatment with testosterone or oestradiol in the neona-
tal period will prevent the development of the GnRH ⁄ LH surge sys-
tem in females (8–10). In males, testosterone is secreted from the
developing testis and is subsequently aromatised in the brain and
other tissues to oestradiol by the enzyme aromatase. Prenatal treat-
ment with the aromatase inhibitor, 1,4,6-androstatrien-3,17-dione
disrupts LH responses to oestradiol in adult male guinea pigs (11),
and affects male-typical sex behaviour in guinea pigs (12), sheep
(13) and rats (14–16), indicating that the prenatal aromatisation of
testosterone to oestradiol is crucial to the normal development of
reproductive behaviours and responses to gonadal hormones in
adulthood. Accordingly, perinatal treatment with exogenous oestra-
diol defeminises the GnRH ⁄ LH system in female rats (9, 17, 18).
Further evidence for a defeminising role for oestradiol is found in
female mice which, as a result of a targeted mutation of the Afp
gene, lack the foetal circulating oestradiol-binding protein, a-foeto-
protein and thus the protection against maternal oestrogens (19).
Previous work in our laboratory shows that Afp null female mice
do not show any LH surges after treatment with oestradiol and
progesterone (20), indicating that exposure to oestradiol during the
prenatal period defeminises the GnRH surge system. However, the
exact mechanism by which oestradiol defeminises the potential to
show such steroid-induced LH surges has not been fully identified.
It is possible that another neuropeptide system organised by oes-
tradiol also plays a role in the organization of the GnRH ⁄ LH surge
system. Recent studies have focused on the role of kisspeptin, a
small peptide that appears to play a crucial role in GnRH secretion.
Kisspeptin stimulates GnRH secretion via its receptor, GPR54 (now
known as Kiss1r), which is present on GnRH neurones (21). Treat-
ment with kisspeptin stimulates LH secretion in many species,
including mice (22), rats (23), sheep (21, 24), monkeys (25) and
humans (26). Treatment with kisspeptin antibodies or antagonists
can block the ability to show an LH surge in female rats (27, 28). In
addition, the expression of this peptide is sexually dimorphic in
rodents: the number of kisspeptin neurones in the rostral periven-
tricular area of the third ventricle (RP3V), an area comprised of the
anteroventral periventricular (AVPV), periventricular preoptic and
median preoptic nuclei (29), is much higher in females than in males
(30), suggesting that this brain area may play an important role in
the sexually dimorphic control of GnRH secretion. Another popula-
tion of kisspeptin neurones exists in the arcuate nucleus; however,
this population is not sexually dimorphic in adulthood and not con-
sidered to be implicated in the generation of the LH surge in rodents
(31). Kisspeptin neurones express oestradiol receptor (ER)a and pro-
gesterone receptors (32–34) and oestradiol treatment increases kiss-
peptin expression in the RP3V (35), whereas GnRH neurones only
appear to contain ERb, which does not appear to mediate the
effects of oestradiol on the generation of the GnRH ⁄ LH surge (36–
38). These findings suggest that kisspeptin neurones likely modulate
the effects of gonadal steroids on GnRH secretion. However, the
effects of deletion of the kisspeptin (Kiss-1) gene or Kiss1r gene on
the GnRH ⁄ LH surge system do not provide consistent support for
the necessity of kisspeptin in the generation of steroid-induced LH
surges. One group has found that neither Kiss-1, nor Kiss1r null
mice are capable of generating steroid-induced LH surges (34). By
contrast, another group using a different transgenic mouse line has
shown that Kiss1r null mice are capable of generating a steroid-
induced LH surge (39). Furthermore, Kiss-1r and Kiss null male mice
show increased LH secretion in response to central, but not periph-
eral treatment with NMDA, a potent stimulator of LH secretion (40).
Lastly, female mice in which the majority of kisspeptin- or Kiss1r-
expressing neurones have been genetically ablated show ovarian fol-
licles in all stages of development and are fertile (41), suggesting
that normal reproductive development can occur in the absence of
kisspeptin signalling to GnRH neurones. These conflicting results
may not only be a result of differences in mouse strains used, but
they also illustrate that the role of kisspeptin in the generation of
the LH surge is not completely understood.
Although there is a strong defeminising role for oestradiol in the
development of the GnRH surge system, recent data obtained in
female aromatase knockout (ArKO) mice that cannot synthesise
oestradiol from its androgenic precursor as a result of a targeted
mutation in the Cyp19 gene also suggest that oestradiol may be
necessary to feminise the kisspeptin system. Female ArKO mice
treated with oestradiol and progesterone in adulthood show
decreased levels of lordosis behaviour when paired with a sexually
active male and have reduced numbers of kisspeptin neurones in
the RP3V (42, 43). Oestradiol treatment alone fails to induce ovula-
tion in female ArKO mice (44), indicating a possible link between
the lack of ovulation (and presumably steroid-induced LH surges)
and the absence of a female-typical population of kisspeptin in the
RP3V. Clarkson and Herbison (45) have shown that ovariectomy of
female mice at postnatal day (P)15 results in a 70–90% reduction
in kisspeptin expression within the RP3V analysed at either P30 or
P60, whereas treatment with 17b-oestradiol in P15-ovariectomised
mice from P15–30 or P22–30 resulted in a complete restoration of
kisspeptin expression in this brain region, indicating that oestradiol
can affect the organisation of the kisspeptin system after the peri-
natal period. Conversely, female rats treated with oestradiol at birth
show reduced numbers of kisspeptin-expressing neurones in the
rostral hypothalamus (9). Taken together, these results suggest that
oestradiol not only affects the organisation of the brain during the
prenatal and neonatal period, but also can act during the prepuber-
tal period to organise the kisspeptin system.
Therefore, in the present study, we tested the hypothesis that
oestradiol is necessary to feminise the capacity to show preovula-
tory LH surges by determining whether female ArKO mice are capa-
ble of showing steroid-induced LH surges. In addition, we also
investigated the potential of ArKO males to show steroid-induced
LH surges aiming to confirm the hypothesis that oestradiol defemi-
nises the potential to show preovulatory LH surges in this sex. If
oestradiol only defeminises the potential to show an LH surge, we
would expect that both ArKO males and females would show an LH
surge. If oestradiol is required to feminise the LH surge system, we
would expect that neither ArKO males, nor ArKO females would
show a steroid-induced surge of LH. Interestingly, ArKO males and
GnRH activation in male and female ArKO mice 1223
Journal of Neuroendocrinology, 2012, 24, 1222–1233 ª 2012 The Authors.
Journal of Neuroendocrinology ª 2012 British Society for Neuroendocrinology
ArKO females have low numbers of kisspeptin neurones (43); thus,
if ArKO mice fail to show a steroid-induced LH surge, this may be a
result of this decreased population of kisspeptin neurones in the
RP3V. To test the hypothesis that a female-typical number of kiss-
peptin neurones is necessary for a steroid-induced LH surge, the
number of cells expressing Kiss-1 mRNA and kisspeptin protein in
the RP3V of ArKO mice was determined at and around the time of
the expected LH surge.
Materials and methods
Animals
The present study used aromatase knockout mice with a targeted disruption
of exons 1 and 2 of the Cyp19 gene (46, 47). All breeding and genotyping
were carried out at the department GIGA Neurosciences, University of Lie`ge,
Belgium. Heterozygous males and females of the CD1 (Swiss-Webster) strain
were bred to generate wild-type (WT) and knockout (ArKO) offspring. Geno-
typing was performed by polymerase chain reaction analysis of tail DNA
(48). Food and water were available ad lib. and the temperature was main-
tained at 22 C. All experiments were conducted in accordance with the
guidelines set forth by the National Institutes of Health Guiding Principles
for the Care and Use of Research animals and were approved by the Ethical
Committee for Animal Use of the University of Liege.
Surgery
Adult (3–6 months) WT and ArKO mice of both sexes were anaesthetised
using an s.c. injection of ketamine (80 mg ⁄ kg per mouse) and medetomidine
(Domitor, Pfizer (Domitor Pfizer Animal Health BV, Capelle a/d Ijssel, the
Netherlands; 1 mg ⁄ kg per mouse) and the gonads were removed. At the
same time as gonadectomy, all mice were implanted s.c. with a silastic cap-
sule (5 mm in length, inner diameter 1 mm, outer diameter 2 mm) contain-
ing 1 lg of 17b-oestradiol dissolved in 7.35 ll of sesame oil (SO) to
maintain the negative-feedback effects of low levels of oestradiol on circu-
lating gonadotrophins. At the end of surgery, all mice received an s.c. injec-
tion of atipamezole (Antisedan, Pfizer; 4 mg ⁄ kg per mouse) to antagonise
medetomidine-induced effects and accelerate recovery. After surgery, mice
were placed in individual cages, and males and females were housed in dif-
ferent rooms under a reversed 12 : 12 h light ⁄ dark cycle.
Experiment 1: Determinination of whether ArKO mice can
generate a steroid-induced activation of GnRH neurones
and a plasma LH surge
Hormone treatment
One week (7 days) after gonadectomy, WT and ArKO mice were divided into three
groups: Group 1 mice [oestradiol benzoate (EB) + progesterone (P): WT ⁄ male,
n = 10; ArKO ⁄ male, n = 11; WT ⁄ female, n = 9; ArKO ⁄ female, n = 8] received
an s.c. injection of EB (1 lg ⁄ 20 g body weight ⁄ 0.05 ml of SO) 4 h before the
onset of the dark period (day 8) and, 24 h later (day 9), an s.c. injection of proges-
terone (500 lg in 0.05 ml of SO) to induce an LH surge; group 2 mice (EB only:
WT ⁄ male, n = 11; ArKO ⁄ male, n = 11; WT ⁄ female, n = 7; ArKO ⁄ female n = 8)
received only an EB injection (day 8) and nothing on day 9, and group 3 mice
(implant only: WT ⁄ male, n = 10; ArKO ⁄ male, n = 11; WT ⁄ female, n = 6;
ArKO ⁄ female, n = 7) received no additional steroid injections on either day 8 or
day 9. At the expected time of the LH surge (within 1 h of the onset of the
dark period, day 9 of treatment), mice were anaesthetised with an overdose of
ketamine (160 mg ⁄ kg ⁄ mouse) and medetomidine (2 mg ⁄ kg ⁄ mouse). Approxi-
mately 1 ml of blood was drawn via cardiac puncture for LH assay. Next, all mice
were perfused transcardially with saline followed by 4% cold paraformaldehyde.
Brains were removed and post-fixed in 4% paraformaldehyde for 2 h at room
temperature (RT). Brains were then placed in a 30% sucrose solution at 4 C until
they sank, and were then frozen on dry ice and stored at )80 C. Brains were
sliced coronally on a cryostat from the rostral telencephalon to the posterior
hypothalamus making four sets of 30 lm sections. Sections were saved in cryo-
protectant solution and stored at )20 C for immunohistochemistry for
GnRH ⁄ Fos and in situ hybridisation for Kiss-1 mRNA levels. As a result of techni-
cal problems, not all samples used for immunohistochemistry had sufficient tis-
sue remaining for in situ hybridisation, and the group numbers used for in situ
hybridisation were: for EB + P treatment: WT ⁄ males, n = 7; ArKO ⁄ males,
n = 7; WT ⁄ females, n = 6; ArKO ⁄ females, n = 6; for EB only treatment:
WT ⁄ males, n = 4; ArKO ⁄ males, n = 5; WT ⁄ females, n = 6; ArKO ⁄ females,
n = 6; for implant only treatment: WT ⁄ males, n = 5; ArKO ⁄ males, n = 6;
WT ⁄ females, n = 5; ArKO ⁄ females, n = 5.
Immunohistochemistry and data analysis for
paraformaldehyde-fixed tissue
We previously showed that the steroid-induced LH surge was accompanied
by an induction of Fos, the protein product of the immediate early gene,
c-Fos, in GnRH neurones (20). Therefore, in the present study, we performed
double-labelling immunohistochemistry on the brain sections to determine
the co-localisation of Fos- and GnRH-expressing neurones in the preoptic
area. Primary antibodies were specific for Fos polyclonal antibody (dilution
1 : 2000; sc-52 rabbit Fos pAB; Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA) and GnRH I [dilution 1 : 1000; GnRH I (Fl-92); Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA, USA]. In experiment 1, double-label immunohis-
tochemistry sections were first rinsed in 0.01 M phosphate-buffered saline
(PBS) (pH 7.4), then peroxidase activity was blocked in a 1 : 4 metha-
nol : PBS solution with 3% H2O2. After peroxidase blocking, sections were
rinsed in PBS-0.1% Triton-X 100 (PBST) and then incubated in a solution of
5% normal goat serum (NGS) in PBST. Sections were then incubated over-
night in a solution of Fos Ab in NGS (Fos Ab, dilution 1 : 2000) at 4 C. The
next day, sections were rinsed in PBST, and then incubated in polyclonal
goat anti-rabbit biotinylated secondary antibody (dilution 1 : 1000 in PBST;
Dako, Glostrup, Denmark) for 1 h at RT. Sections were washed in PBST and
incubated in the Vectastain Elite ABC Kit (PK6100; Vector Laboratories, Bur-
lingame, CA, USA), then rinsed in PBST. After rinsing in a solution of 0.05 M
Tris-HCl, sections were developed with the DAB substrate Kit (SK-4100; Vec-
tor Laboratories) to give a black precipitate [3,3¢-diaminobenzidine (DAB)
+Ni2+]. Sections were then rinsed in MilliQ H2O (Millipore, Billerica, MA, USA)
followed by PBS, re-fixed in 4% paraformaldehyde and the residual peroxi-
dase activity was blocked in 1 : 4 methanol : PBS solution. Sections were
rinsed in PBST then incubated in GnRH pAb (dilution 1 : 1000) at 4 C for
24 h, respectively. Next, secondary antibody and ABC steps were performed
as described above, and the tissue was developed using Vector NovaRED
substrate Kit (SK-4800; Vector Laboratories) to produce a red precipitate.
Sections were then mounted on slides, dried and cover slipped in Eukitt
(Sigma, Bornem, Belgium).
For GnRH and Fos ⁄ GnRH double-labelled cells, the counting area was
located within the preoptic area (interaural 4.42–4.30 mm and Bregma
0.62–0.50 mm), as previously described (49). Both hemispheres of two brain
sections (with an interval of 120 lm between sections) were counted.
In situ hybridisation of Kiss mRNA levels: preparation of
riboprobe
A plasmid containing mouse Kiss1 riboprobe was generously provided by Dr
Alexander Kauffman (Department of Reproductive Medicine and the Centre
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for Chronobiology, University of California, San Diego, La Jolla, CA, USA). The
sequence of the riboprobe spans bases 78–486 of the mouse Kiss1 gene
(Genbank accession number AF473576). The plasmid was heat-transfected
and amplified in competent Escherichia coli DH5a cells. The circular plasmid
was extracted from these cells and purified using the QIA Filter Plasmid
Midi-Kit (Qiagen Inc., Valencia, CA, USA). Plasmids were linearised by incuba-
tion with HindIII restriction enzyme (Roche Diagnostics GmbH, Mannheim,
Germany) and the linearised DNA was purified using QIAprep Spin Miniprep
Kit (Qiagen Inc.). The antisense Kiss1 probe was synthesised using T7 tran-
scription enzyme, DIG labelling mix, and RNAase inhibitors (Roche Diagnos-
tics GmbH). The antisense probe was purified in Sephadex G-50 columns
(Kit-Illustra microspin G50 columns; GE Healthcare, Milwaukee, WI, USA).
In situ hybridisation
Free-floating brain sections prepared as previously described for immunohis-
tochemistry were used for in situ hybridisation. Sections were washed in
PBS-diethylpyrocarbonate (DEPC) then briefly post-fixed with 4% parafor-
maldehyde. Sections were washed again in PBS-DEPC and then treated with
100 mM triethanolamine acetylated with 0.25% acetic acid. Sections were
washed with PBS-Tween 0.1% and then pre-hybridised with pre-warmed
hybridization buffer for 1 h at 70 C. Sections were then hybridised with a
mix of 4 ll DIG-labelled Kiss1 probe and 250 l of pre-warmed hybridisation
buffer overnight in a 70 C water bath. Sections were washed in washing
buffer (50% formamide, 2·SSC, 0.1% Tween) at 72 C, washed in buffer B1
(100 mM Tris-HCl pH 7.5, 150 nM NaCl, 0.1% Tween) at RT, then blocked in
buffer B2 (10% NGS in buffer B1) for 1 h 15 min at RT. Next, tissue was
incubated with anti-DIG coupled to alkaline phosphatase (Anti-DIG-AP Fab
fragments; Roche Diagnostics GmbH) diluted 1 : 2000 in B2 overnight at
4 C. Tissue was washed in B1 then incubated in B3 (100 mM Tris pH 9.5,
100 mM NaCl, 50 mM MgCl2, 0.1% Tween) at RT. Next, tissue was added to
3–400 ll of filtered NBT ⁄ BCIP liquid substrate system (Sigma Aldrich, St.
Louis, MO, USA) in the dark for 1 h at RT. The tissue was transferred to
fresh NBT ⁄ BCIP and the reaction was allowed overnight in the dark at 4 C
until the desired signal was reached. Tissue was washed in PBS-Tween to
stop the reaction, and was mounted on slides in an aqueous gelatin medium
and coverslipped. After allowing the slides to dry, Kiss1-mRNA containing
cells were counted. The counting areas were limited to the rostral hypothal-
amus within interaural: 4.06–3.94 mm and Bregma 0.26–0.14 mm according
to Franlyn and Paxinos (50). Both hemispheres of two to four brains sec-
tions (with an interval of 120 lm between sections) were counted.
Experiment 2: comparison of numbers of
kisspeptin-immunoreactive neurones before and after the
steroid-induced LH surge in ArKO versus WT mice
In Experiment 1, we observed that ArKO mice of both sexes were clearly
capable of showing a steroid-induced LH surge at the same time as having
a decreased level of Kiss-1 mRNA expression in the RP3V, which might
question the role of kisspeptin in regulating the preovulatory LH surge.
Therefore, we conducted a second experiment to determine the expression
of kisspeptin protein before and during the steroid-induced surge of LH.
Hormone treatment
A new batch of WT and ArKO mice was gonadectomised and implanted with
silastic capsules containing oestradiol as described in Experiment 1. One
week (7 days) after gonadectomy, mice were divided into four groups: group
1 mice received a s.c. injection of oestradiol benzoate (EB) (1 lg ⁄ 20 g body
weight ⁄ 0.05 ml of SO) 4 h before the onset of the dark period (day 8) and,
24 h later (day 9), an s.c. injection of progesterone (500 lg in 0.05 ml of SO)
to induce an LH surge. Two animals had plasma LH concentrations that were
more than ten-fold lower than the others in the same sex ⁄ genotype (WT ⁄ fe-
male, ArKO ⁄ male) and so were removed from the study (resulting group
numbers for EB + P: WT ⁄ male, n = 4; ArKO ⁄ male, n = 3; WT ⁄ female, n = 4;
ArKO ⁄ female, n = 5); group 2 mice received only an EB injection (day 8) and
nothing on day 9 (EB only: WT ⁄ male, n = 5; ArKO ⁄ male, n = 4; WT ⁄ female,
n = 6; ArKO ⁄ female, n = 5) and group 3 mice received no additional steroid
injections on either day 8 or day 9 (implant only: WT ⁄ male, n = 5; ArKO ⁄ fe-
male, n = 4; WT ⁄ female, n = 5; ArKO ⁄ female, n = 5). All mice in groups 1–3
were sacrificed at the expected time of the LH surge (within 1 h of the onset
of the dark period, on day 9 of treatment). An additional group received an
injection of EB on day 8 and progesterone on day 9, and were sacrificed 2 h
before the expected time of the LH surge (EB + P – 2 h: WT ⁄ male, n = 6;
ArKO ⁄ male, n = 4; WT ⁄ female, n = 5; ArKO ⁄ female, n = 5).
At the time of sacrifice, mice were anaesthetised with an overdose of ke-
tamine (160 mg ⁄ kg ⁄ mouse) and medetomidine (2 mg ⁄ kg ⁄ mouse). Approxi-
mately 1 ml of blood was drawn via cardiac puncture for LH assay. Next,
the brains were removed and fixed in 5% acrolein solution for 2.5 h, and
then rinsed 2 · 30 min in PBS at RT. We used acrolein as fixative because
we observed only few kisspeptin-immunoreactive (-IR) neurones in ArKO
mice when brains were fixed with paraformaldehyde (43). In addition, the
type of fixative used for immunohistochemistry can affect staining (51).
Brains were then placed in a 30% sucrose solution at 4 C until they sank,
and were then frozen on dry ice and stored at )80 C until use. Brains were
sliced coronally on a cryostat from the rostral telencephalon to the posterior
hypothalamus, making four sets of 30-lm sections. Sections were saved in
cryoprotectant solution and stored at )20 C for immunohistochemistry. .
Immunohistochemistry and data analysis for acrolein-fixed
tissue
We performed double-labelling immunohistochemistry on the brain sections
to determine the co-localization of Fos- and Kisspeptin-IR neurones in the
rostral hypothalamus. Immunohistochemical procedures were very similar to
those described for Experiment 1, with the exception that all rinses were
performed in Tris buffer solution (pH 7.4) and that sections were first incu-
bated in 1% sodium borohydride solution and tissue was developed with
the DAB substrate Kit (SK-4100; Vector Laboratories) to give a brown precip-
itate for kisspeptin immunoreactivity. Primary antibodies were specific for
Fos polyclonal antibody (dilution 1 : 2000; sc-52 rabbit Fos pAB, Santa Cruz
Biotechnology Inc.), and kisspeptin (dilution 1 : 5000; rabbit pAb donated by
Dr A. Caraty, UMR Physiologie de la Reproduction et des Comportements,
INRA, Nouzilly France). Sections were incubated in kisspeptin antibody for
72 h at 4 C. This concentration of kisspeptin antibody was chosen after
testing with lower and higher concentrations and found to provide the best
quality labelling in our laboratory. For Kisspeptin and Fos ⁄ Kisspeptin double-
labelled cells, the counting areas were limited to the rostral hypothalamus
within interaural: 4.06–3.94 mm and Bregma 0.26–0.14 mm according to
Franklin and Paxinos (50). Both hemispheres of three to four brains sections
(with an interval of 120 lm between sections) were counted.
LH analysis
Serum LH levels were determined in duplicate in a volume of 100 ll using a
double-antibody method and radioimmunoassay kits, kindly supplied by the
National Institute of Health (Dr A. F. Parlow, National Institute of Diabetes
and Kidney Diseases, National Hormone and Peptide Program, Torrance, CA,
USA). Rat LH-I-10 (AFP-11536 B) was labelled with 125I by the chloramine-T
method. The hormone concentrations were expressed using the mouse LH
reference preparation (AFP-5306A) as standard. The intra-assay and inter-
assay coefficients of variations were less than 7% and 10% respectively. The
sensitivity of the assay was 0.04 ng ⁄ ml.
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Statistical analysis
Two-way ANOVAs with genotype ⁄ sex and treatment as factors were carried
out for all dependent variables (STATISTICA, version 9; StatSoft, Inc., Tulsa, OK,
USA). When appropriate, the ANOVAs were followed by Fisher’s least signifi-
cant difference post-hoc comparisons (for the percentage Fos ⁄ GnRH data,
the one-tailed test was used, whereas a two-tailed test was used for all
other data). P < 0.05 was considered statistically significant.
Results
Experiment 1: Determinination of whether ArKO mice can
generate a steroid-induced activation of GnRH neurones
and a plasma LH surge
Plasma LH levels
Treatment with EB + P induced a LH surge in WT females and ArKO
mice of both sexes but not in WT males (Fig. 1A), supporting the
hypothesis that oestradiol defeminises the GnRH ⁄ LH surge system.
The two-way ANOVA indicated a significant effect of genotype ⁄ sex
(F3,97 = 12.43, P < 0.0001), treatment (F2,97 = 28.58, P < 0.0001)
and a significant genotype ⁄ sex · treatment interaction (F6,97 = 8.22,
P < 0.0001). Post-hoc analysis showed that, in WT female mice,
treatment with EB + P resulted in higher plasma concentrations of
LH compared to EB treatment (P < 0.05) or implant alone
(P < 0.01). ArKO female mice treated with EB + P also showed sig-
nificantly higher plasma concentrations of LH than ArKO female
mice given EB (P < 0.0001) or implant only (P < 0.0001), indicating
that female ArKO mice are capable of showing steroid-induced LH
surges. ArKO males treated with EB + P had significantly higher
concentrations of plasma LH than ArKO males treated with EB
(P < 0.0001) or given an implant only (P < 0.0001), and ArKO males
treated with EB + P also had significantly higher concentrations of
plasma LH than WT males given EB + P (P < 0.0001), indicating
that ArKO males are also capable of showing steroid-induced LH
surges. WT male mice treated with EB + P had significantly lower
plasma concentrations of LH than WT male mice given an implant
only (P < 0.05) but did not differ significantly from WT male mice
treated with EB only (P = 0.78).
Number of GnRH-IR neurones and percentage of
double-labelled Fos ⁄GnRH neurones
In accordance with plasma LH concentrations, subsequent treat-
ment with EB + P induced Fos protein in GnRH neurones in the
preoptic area in WT females and ArKO mice of both sexes but not
in WT males (Fig. 1B). There were no significant differences between
groups in the number of GnRH-IR neurones in the preoptic area
(Table 1); however, differences in the percentage of double-labelled
Fos ⁄GnRH neurones were found (Fig. 1B). Images of the Fos ⁄GnRH
staining are presented in Fig. 2. Two-way ANOVA revealed significant
main effects of genotype ⁄ sex (F3,97 = 7.49, P < 0.001) and treat-
ment (F2,97 = 18.68, P < 0.001) and a significant geno-
type ⁄ sex · treatment interaction (F6,97 = 3.86, P < 0.001). Post-hoc
analysis indicated that WT female mice treated with EB + P had a
higher percentage of double-labelled Fos ⁄GnRH neurones than WT
female mice treated with EB (P = 0.05) or implant only (P = 0.05),
and also differed significantly from WT males treated with EB + P
(P < 0.05). ArKO female mice treated with EB + P also showed a
significantly higher percentage of double-labelled Fos ⁄GnRH neuro-
nes than ArKO female mice given EB (P < 0.01) or implant only
(P < 0.01). ArKO males treated with EB + P had a higher percent-
age of double-labelled Fos ⁄GnRH neurones than ArKO males trea-
ted with EB (P < 0.0001) or implant only (P < 0.0001), and ArKO
males treated with EB + P had a significantly higher percentage of
double-labelled Fos ⁄GnRH neurones than WT males treated with
EB + P (P < 0.0001), indicating that the LH surge produced in WT
female mice and ArKO mice of both sexes in response to EB + P is






























































Fig. 1. Capacity of aromatase knockout (ArKO) mice to show a steroid-induced
luteinising hormone (LH) surge. (A) Mean  SEM plasma concentrations of LH
(ng ⁄ ml) and (B) Mean  SEM percentage of gonadotrophin-releasing hor-
mone (GnRH) neurones co-expressing Fos ⁄ section in the preoptic area in
gonadectomised male and female wild-type (WT) and ArKO mice given a
silastic implant containing 1lg of 17b-oestradiol in 7.35 ll of sesame oil
for 1 week, then treated with injections of oestradiol benzoate (EB) and
progesterone (EB + P), oestradiol only (EB only) or no further injections (no
added treatment). *P < 0.05. **P < 0.01). The number of animals per experi-
mental group is given in parentheses.
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Number of neurones containing Kiss-1 mRNA
ArKO mice were capable of generating a steroid-induced LH surge
despite having significantly fewer Kiss-1 expressing cells in the
RP3V compared to WT female mice (Fig. 3), which does not support
the hypothesis that WT female-typical numbers of kisspeptin neuro-
nes in the RP3V are necessary for the generation of the LH surge.
Two-way ANOVA of the number of neurones containing Kiss-1 mRNA
in the RP3V revealed that there were significant main effects of
genotype ⁄ sex (F3,56 = 150.81, P < 0.001) but no significant effect
of treatment or genotype ⁄ sex · treatment interaction. Post-hoc
analysis confirmed that WT female mice had a significantly higher
number of neurones containing Kiss-1 mRNA in the RP3V than WT
males and ArKO mice of both sexes, regardless of hormonal treat-
ment (P < 0.01). WT males had a significantly lower number of
neurones containing Kiss-1 mRNA in the RP3V than WT females
and ArKO mice of both sexes (P < 0.01).
Experiment 2: Comparison of numbers of kisspeptin-IR
neurones before and after the steroid-induced LH surge in
ArKO versus WT mice
Number of kisspeptin-IR neurones and percentage of
double-labelled Fos ⁄ kisspeptin neurones in acrolein-fixed
tissue
As shown previously (43), WT female mice had a greater number of
kisspeptin-IR neurones in the RP3V than WT male mice and ArKO
mice of both sexes at the expected time of the LH surge, regardless
of hormonal treatment (Fig. 4A). The number of kisspeptin-IR neuro-
nes in EB + P treated mice killed 2 h before the expected surge of
LH was not significantly different from that at the time of the LH
surge. Thus, the low numbers of kisspeptin-IR neurones in ArKO
male and female mice showing a steroid-induced surge of LH is
not likely the result of a EB + P induced depletion of kisspeptin
Table 1. Mean  SEM Number of Gonadotrophin-Releasing Hormone (GnRH) Neurones in the Preoptic Area in Gonadectomised Male and Female Wild-Type
(WT) and Aromatase Knockout (ArKO) Mice Given a Silastic Implant Containing 1 lg of 17b-Oestradiol in 7.35 ll of Sesame Oil for 1 Week, Then Treated With
Injections of Oestradiol Benzoate (EB) and Progesterone (EB + P), Oestradiol Only (EB only) or No Further Injections (No Added Treatment).
Treatment
WT ⁄ male KO ⁄ male WT ⁄ female KO ⁄ female
GnRH n GnRH n GnRH n GnRH n
EB + P 34.6  5.6 10 36.1  3.4 11 26.6  2.6 9 29.5  4.2 8
EB only 29.6  6.2 11 30.2  3.9 11 26.1  3.1 7 28.4  5.3 8
No added treatment 36  3.1 10 27.3  3.8 11 26.3  5.2 6 27.6  6.0 7





(A) (B) (C) (D)
(E) (F) (G) (H)
(I) (J) (K) (L)
Fig. 2. Representative photomicrographs (· 40) of gonadotrophin-releasing hormone (GnRH) neurones in the preoptic area of gonadectomised male and female
wild-type (WT) and aromatase knockout (ArKO) mice given a silastic implant containing 1 lg of oestradiol in 7.35 ll of sesame oil and then treated with injec-
tions of oestradiol benzoate and progesterone (EB + P), oestradiol only (EB only) or no further injections (no additional treatment). (A) Female WT mouse treated
with EB + P. (B) Male WT mouse treated with EB + P. (C) Female ArKO mouse treated with EB + P.(D) Male ArKO mouse treated with EB + P. (E) Female WT mouse
treated with EB only. (F) Male WT mouse treated with EB only. (G) Female ArKO mouse treated with EB only. (H) Male ArKO mouse treated with EB only. (I) Female
WT mouse given silastic implant only. (J) Male WT mouse given silastic implant only. (K) Female ArKO mouse given silastic implant only. (L) Male ArKO mouse
given silastic implant only. Open arrows indicate GnRH neurones, whereas closed arrows indicated Fos-activated GnRH neurones. Scale bar = 50 lm.
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in the RP3V. The two-way ANOVA of the number of kisspeptin-IR
neurones in the RP3V revealed significant main effects of geno-
type ⁄ sex (F3,60 = 118.29, P < 0.001) but no significant effect of
treatment or genotype ⁄ sex · treatment interaction. Post-hoc analy-
sis of this effect revealed that WT female mice had a higher num-
ber of kisspeptin-IR neurones ⁄ section than WT male mice and ArKO
mice of both sexes (P < 0.001). WT male mice had a lower number
of kisspeptin-IR neurones ⁄ section than WT females and ArKO mice
of both sexes (P < 0.001).
WT female mice had a higher percentage of double labelled
Fos ⁄ kisspeptin neurones ⁄ section in the RP3V compared to WT male
mice and ArKO mice of both sexes (Fig. 4B). Two-way ANOVA of the
number of double-labelled Fos ⁄ kisspeptin-neurones in the RP3V
revealed significant main effects of genotype ⁄ sex (F3,60 = 95.40,
P < 0.001) but no significant effect of treatment or geno-
type ⁄ sex · treatment interaction. Post-hoc analysis of this effect
revealed that WT female mice had a higher percentage of double-
labelled Fos ⁄ kisspeptin neurones than WT males and ArKO mice of
both sexes, regardless of treatment (P < 0.001). WT males had a
lower percentage of double-labelled Fos ⁄ kisspeptin neurones than
WT and KO females, regardless of treatment (P < 0.05). Images of
Fos ⁄ Kisspeptin staining are presented in Fig. 5.
Plasma LH levels
As observed in Experiment 1, treatment with EB + P induced a LH
surge in WT females and ArKO mice of both sexes but not in WT
males (Fig. 6). As a result of technical problems, two samples could
not be analysed (the adjusted group numbers are noted). Two-way
ANOVA indicated a significant effect of genotype ⁄ sex (F3,58 = 10.23,
P < 0.001), treatment (F3,58 = 10.99, P < 0.001) and a significant
genotype ⁄ sex · treatment interaction (F9,58 = 6.72, P < 0.001).
Post-hoc analysis showed that, in WT female mice, treatment with
EB + P resulted in higher plasma concentrations of LH compared to
implant only (P < 0.05). ArKO female mice treated with EB + P also
had significantly higher plasma concentrations of LH than all other
groups (P < 0.05), indicating that female ArKO mice are capable of
showing steroid-induced LH surges. In addition, the fact that ArKO
females treated with EB + P had significantly higher plasma con-
centrations than ArKO females treated with EB + P and sacrificed
2 h before the expected surge (EB + P – 2 h, P < 0.001) indicates
that the LH surge is occurring at the time of sacrifice (4 h after
progesterone injection, within 1 h of the onset of the dark period)
in these animals. Similarly, ArKO males treated with EB + P had
significantly higher concentrations of plasma LH than ArKO males
given an implant only (P < 0.001) and ArKO males treated with
EB + P and sacrificed 2 h before the expected time of the LH surge
(P < 0.0001). As observed in Experiment 1, WT male mice treated
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Fig. 3. Mean  SEM number of Kiss-1 mRNA-expressing neurones ⁄ section
in the rostral periventricular area of the third ventricle of gonadectomised
male and female wild-type (WT) and aromatase knockout (ArKO) mice given
a silastic implant containing 1 lg of 17b-oestradiol in 7.35 ll of sesame oil
for 1 week, then treated with injections of oestradiol benzoate and proges-
terone (EB + P), oestradiol only (EB only) or no further injections (no added
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Fig. 4. (A) Mean  SEM number of kisspeptin-expressing neurones ⁄ section
and (B) mean  SEM percentage of kisspeptin-immunoreactive neurones co-
expressing Fos-IR ⁄ section in the rostral periventricular area of the third ven-
tricle of gonadectomised male and female wild-type (WT) and aromatase
knockout (ArKO) mice given a silastic implant containing 1 lg of 17b-oes-
tradiol in 7.35 ll of sesame oil for 1 week, then treated with injections of
oestradiol benzoate (EB) and progesterone (P) and sacrificed 2 h before the
expected luteinising hormone (LH) surge (EB + P – 2 h), or sacrificed at the
expected time of the LH surge after injections of oestradiol benzoate and
progesterone (EB + P), oestradiol only (EB only) or no further injections (no
added treatment). Groups with different letter notations are significantly dif-
ferent from one another within the same genotype ⁄ sex (P < 0.05). The
number of animals per experimental group is given in parentheses.
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than WT male mice given an implant only (P < 0.05). It is important
to note that there were no significant differences between
sex ⁄ genotype in the EB + P – 2 h groups, indicating that, 2 h
before the expected time of the LH surge, there is no difference in
plasma concentrations of LH between sex or genotype. Thus, the
timing of the expected LH surge is likely to be accurate in this
experiment.
Discussion
The present study shows that both male and female ArKO mice
were capable of generating an LH surge in response to adult treat-
ment with EB + P, lending further support to the idea that oestra-
diol defeminises the capacity to show steroid-induced activation of
GnRH neurones and, by consequence, an LH surge in male mice.
The finding that female ArKO mice showed LH surges when treated
with EB + P in adulthood indicates that this particular female char-
acteristic develops in the absence of any previous developmental
action of oestradiol. Development of this female-typical neuroendo-
crine circuit differs from the organisation of the neural circuits
underlying courtship behaviours, which require feminisation by oes-
tradiol during prepubertal development (42, 52). Oestradiol presum-
ably acts prenatally because female mice that lack a-foetoprotein, a
foetal circulating oestradiol-binding protein that protects against
maternal oestradiol (19), do not show an LH surge after treatment
with EB + P (49).
Interestingly, ArKO mice did not have female-typical numbers of
kisspeptin-IR or Kiss-1 mRNA expressing neurones in the RP3V,
indicating that the steroid-induced LH surge occurred with a
reduced population of kisspeptin neurones. Furthermore, kisspeptin
neurones in ArKO mice showed reduced Fos co-expression after
EB + P treatment compared to WT female mice, raising the
WT female WT male ArKO female ArKO male
EB + P
EB + P – 2 h
No additional
treatment
(A) (B) (C) (D)
(E) (F) (G) (H)
(I) (J) (K) (L)
Fig. 5. Representative photomicrographs (· 20) of kisspeptin and Fos ⁄ kisspeptin neurones in the rostral periventricular area of the third ventricle of gonadec-
tomised male and female wild-type (WT) and aromatase knockout (ArKO) mice given an silastic implant containing 1 lg of oestradiol in 7.35 ll of sesame oil
then treated with injections of oestradiol benzoate and progesterone (EB + P), oestradiol and progesterone then sacrificed 2 h prior to the expected time of
the LH surge (EB + P – 2h), or no further injections (no additional treatment). (A) Female WT mouse treated with EB + P. (B) Male WT mouse treated with
EB + P. (C) Female ArKO mouse treated with EB + P. (D) Male ArKO mouse treated with EB + P. (E) Female WT mouse treated with EB + P – 2h. (F) Male WT
mouse treated with EB + P – 2h. (G) Female ArKO mouse treated with EB + P – 2h. (H) Male ArKO mouse treated with EB + P – 2h. (I) Female WT mouse given
silastic implant only. (J) Male WT mouse given silastic implant only. (K) Female ArKO mouse given silastic implant only. (L) Male ArKO mouse given silastic
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Fig. 6. Capacity of aromatase knockout (ArKO) mice to show a steroid-
induced luteinising hormone (LH) surge. Mean  SEM plasma concentra-
tions of LH (ng ⁄ ml) in gonadectomised male and female WT and ArKO mice
given a silastic implant containing 1 lg of 17b-oestradiol in 7.35 ll of ses-
ame oil for 1 week, then treated with injections of oestradiol benzoate (EB)
and progesterone (P) and sacrificed 2 h before the expected LH surge
(EB + P – 2 h) or sacrificed at the expected time of the LH surge after injec-
tions of oestradiol and progesterone (EB + P), oestradiol only (EB only) or
no further injections (implant only). Groups with different letter notations
are significantly different from one another within the same genotype ⁄ sex
(P < 0.05). The number of animals per group is given in parentheses.
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question of whether this reduced population of kisspeptin neurones
in the RP3V of ArKO females, as well as ArKO males, is essential for
the generation of the steroid-induced GnRH ⁄ LH surge. Kisspeptin
has been proposed to be an important player in the cyclic genera-
tion of preovulatory LH surges because Kiss1r and Kiss1 null mice
do not show an LH surge or Fos ⁄GnRH double-labelling in response
to EB + P. However, a different strain of Kiss1r null mice retains
the capacity to generate a steroid-induced LH surge (39). Similarly,
recent work by Mayer and Boehm (41) showed that female mice, in
which over 95% of kisspeptin- or Kiss1r-expressing neurones were
ablated during embryonic development, show all stages of oestrous
cyclicity and were fertile in adulthood. However, when kisspeptin-
or Kiss1r-expressing neurones are ablated in adulthood, only
females in which Kiss1r-expressing neurones are ablated remained
fertile (41). Nevertheless, there is evidence questioning the absolute
requirement of the full female-typical complement of kisspeptin
neurones in generating GnRH ⁄ LH surges.
The ArKO mouse model permits the study of the differentiation
of the GnRH surge system and the kisspeptin system in the
absence of oestradiol exposure across development. Although
female ArKO mice have altered ovarian phenotype and are infertile
(53), our results showed that the GnRH ⁄ LH surge system was still
capable of generating a steroid-induced LH surge in these mice.
ArKO mice typically show increased plasma concentrations of go-
nadotrophins (presumably as a result of the lack of negative-feed-
back by oestradiol), although treatment with a low dose of
oestradiol decreases plasma LH concentrations to normal levels (53,
54). Our observation of low levels of plasma LH in implant-only
treated ArKO mice of both sexes is consistent with this finding.
ArKO mice are also characterised by higher levels of androgens in
adulthood as a result of the absence of negative-feedback actions
of oestradiol on the hypothalamic-pituitary-gonadal axis (47). It has
been shown that, in male mice, treatment with androgens in adult-
hood can affect kisspeptin expression in the arcuate nucleus and
median eminence, although the Kiss-1 population in the RP3V
appears to be less affected (55). Thus, it is more likely that the
reduced population of kisspeptin neurones in the RP3V of ArKO
mice is a result of the absence of oestradiol during a critical prepu-
bertal period (45) than that it has been defeminised by androgens.
If the latter was true, then ArKO males should have had a male-
typical population of kisspeptin neurones in the RP3V. Typically,
ArKO female mice do not show ovulation in response to oestradiol
treatment in adulthood; however, recently, it has been discovered
that combined treatment with oestradiol, pregnant mare serum
gonadotrophin and human chorionic gondatrophin can indeed
induce ovulation in ArKO female mice (56), suggesting that the
reproductive system has the capacity to function despite high levels
of circulating gonadotrophins.
There is strong evidence that oestradiol plays an important role
in the sexual differentiation of the kisspeptin system during both
pre- and postnatal development (31). Neonatal treatment with
oestradiol defeminises the population of kisspeptin neurones in
the RP3V of females (9, 57, 58), whereas neonatal castration pre-
vents the defeminisation of the number of Kiss-1 mRNA-express-
ing neurones in the RP3V in male rats (9). Although the precise
mechanism of action of oestradiol remains to be elucidated, it is
possible that the defeminising actions of oestradiol on kisspeptin
result from cell death, similar to the oestradiol-induced cell death
in tyrosine hydroxylase-IR neurones in the AVPV (59). Although
recent evidence has suggested that the development of the sexu-
ally dimorphic number of kisspeptin neurones is not dependent
on the proapoptotic protein BAX (B-cell lymphoma 2-associated
protein X) (60), it is possible that oestradiol could regulate cell
death in RP3V kisspeptin neurones via a BAX-independent apop-
totic pathway. It should be noted, however, that the number of
Kiss-1 mRNA expressing neurones is lower in neonatally castrated
male rats compared to female rats (9), suggesting a postnatal
contribution of oestradiol to the development of the kisspeptin
system in females. Indeed, our results, as well as those obtained
previously (30, 45), suggest that oestradiol exerts feminising
effects on kisspeptin neuronal development during the prepubertal
period. If oestradiol only defeminised the numbers of kisspeptin-
expressing neurones in the RP3V, both male and female ArKO
mice, which are characterised by the lack of circulating oestradiol
throughout development (47), should have had a female-typical
population of kisspeptin neurones in the rostral hypothalamus,
which is clearly not the case (43). Furthermore, the development
of kisspeptin neurones in the RP3V appears to occur between
P15 and P30, and the sex differences in this neuronal population
do not emerge until after P10 (30, 45), which is well past the
perinatal surge of testosterone and oestradiol that is considered
to be responsible for the defeminisation of the GnRH ⁄ LH surge
system in males (61, 62). Taken together, these results show that
oestradiol plays a dual role in the sexual differentiation of the
kisspeptin population in the RP3V. It has clear defeminising
effects when present prenatally (49) and shortly after birth (9, 58,
63) that are normally prevented in the female hypothalamus as a
result of the presence of oestradiol-binding a-foetoprotein. In
addition, oestradiol has clear feminising effects during the prepu-
bertal period by inducing a female-typical population of kisspeptin
neurones in the RP3V (45). Presumably, kisspeptin neurones in
the RP3V in males are either not exposed to adequate feminising
levels of oestradiol during this particular prepubertal period or
become insensitive to such actions during postnatal development
and adulthood. Because ArKO mice are deprived of oestradiol dur-
ing both the prenatal and prepubertal period, their kisspeptin
population is neither defeminised, nor feminised, and thus not
completely sexually differentiated. Even so, treatment with EB + P
induced GnRH neurone activation leading to an LH surge in ArKO
mice of both sexes.
In the present study, we observed numbers of kisspeptin-IR neu-
rones and those expressing Kiss-1 mRNA. Consistent with other
rodent studies, a clear sex difference was observed, with WT
females having higher numbers of Kiss-1 mRNA neurones than WT
males (32, 57, 63, 64). By contrast, the numbers of Kiss-1 mRNA
expressing cells were much higher than the numbers of kisspeptin-
IR neurones for all experimental groups. A similar discrepancy
between kisspeptin protein expression and Kiss-1 mRNA content
has been reported by Clarkson and Herbison (65), who have shown
that kisspeptin cell number or their apposition upon GnRH
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neurones remain constant throughout the oestrous cycle, in stark
contrast to the results obtained in other laboratories, which have
shown that Kiss-1 mRNA levels are strongly modulated by gonadal
hormones and vary over the course of the oestrous cycle (35, 66).
The reasons for the discrepancy between kisspeptin protein levels
and Kiss1 mRNA content remain unclear. It could reflect differences
in sensitivity between in situ hybridisation for mRNA and immuno-
histochemistry for the protein. Nevertheless, it is the kisspeptin pro-
tein that interacts with GnRH neurones and thus the essential
marker of kisspeptin function (65). This is particularly relevant to
the lower numbers of kisspeptin protein containing neurones
observed in ArKO mice that were still capable of generating LH
surges in response to EB + P treatment. A possible explanation
might have been that kisspeptin stores were already depleted at
the time of sacrifice, which presumably coincided with the timing
of the LH surge in these animals. However, kisspeptin protein
expression (reflected by the number of kisspeptin-IR neurones) in
mice sacrificed 2 h before the expected time of the LH surge did
not differ significantly from those sacrificed at the time of the LH
surge. Thus, it is unlikely that the low number of kisspeptin-IR neu-
rones seen in ArKO mice was the result of a depletion of kisspeptin
protein in the RP3V before the LH surge. It is also possible that the
kisspeptin system, similar to the GnRH system, only requires a min-
imum number of neurones to permit the induction of the LH surge.
In summary, both male and female ArKO mice showed an activa-
tion of hypothalamic GnRH neurones leading to a plasma LH surge
in response to adult treatment with EB + P. This result has two
implications. First, the GnRH ⁄ LH surge control circuit system is nor-
mally defeminised in male mice by the early actions of oestradiol.
Second, in contrast to its role in feminising the circuits controlling
courtship behaviours, oestradiol is not required to feminise the
GnRH ⁄ LH surge control circuit in female mice. Our observation of
reduced numbers of kisspeptin-IR neurones in ArKO female mice
compared to WT females further suggests that postnatal oestradiol
is normally required to feminise the RP3V kisspeptin system. Our
unexpected result that hormone-induced activation of GnRH neuro-
nes led to a surge of plasma LH in ArKO mice lacking a female-typ-
ical population of RP3V kisspeptin neurones suggests that a
reduced number of kisspeptin neurones may be sufficient for a
functional GnRH ⁄ LH surge system in these mice. It is possible that
compensatory mechanisms have allowed the surges to proceed with
a partially reduced population of kisspeptin neurones in the RP3V
in ArKO mice, or that the female-typical number of RP3V kisspeptin
neurones is redundant, just as the number of preoptic GnRH neuro-
nes in female rodents far exceeds the number needed to generate
preovulatory LH surges (41).
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